![]() WuXi AppTec WuXi AppTec (无锡药明康德新药开发股份有限公司, formerly known as WuXi PharmaTech) is a company that provides integrated research, development, and manufacturing solutions for drug discovery and production. | ![]() Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. | ![]() Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. | ![]() Sanofi Sanofi is a healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions. | ||
Founding Date | Founding Date 1901 | Founding Date 2000 | Founding Date 1996 | Founding Date 1849 | Founding Date 1994 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Petah Tikva, IL HQ Villa Adelina, AR Macquarie Park, AU Minsk, BY Antwerpen, BE Sao Paulo, BR Dupnica, BG see more | Locations Shanghai, CN HQ Beijing, CN Changzhou, CN Chengdu, CN Nanjing, CN Nantong, CN Shanghai, CN see more | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more | Locations Paris, FR HQ Hydra, DZ Buenos Aires, AR Macquarie Park, AU Melbourne, AU Virginia, AU Wien, AT see more |
Employees | Employees 37,000 | Employees 39,414 | Employees 75,883 | Employees 81,0008% decrease | Employees 82,878 |
Valuation ($) | Valuation ($) 20.8 b | Valuation ($) 20.7 b | Valuation ($) N/A | Valuation ($) 163.9 b | Valuation ($) 141.1 b |
Financial | |||||
Revenue (est.) | Revenue (est.) $17.3b (FY, 2025) | Revenue (est.) ¥43.1b (FY, 2025) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) $62.6b (FY, 2025) | Revenue (est.) €45.4b (FY, 2025) |
Cost of goods | Cost of goods $8.3b (FY, 2025) | Cost of goods ¥23.8b (FY, 2025) | Cost of goods $8.4b (FY, 2025) | Cost of goods $16.1b (FY, 2025) | Cost of goods €11.6b (FY, 2025) |
Gross profit | Gross profit $8.9b (FY, 2025) | Gross profit ¥21.3b (FY, 2025) | Gross profit $49.8b (FY, 2025) | Gross profit $46.5b (FY, 2025) | Gross profit €37.6b (FY, 2025) |
Net income | Net income $1.4b (FY, 2025) | Net income ¥19.3b (FY, 2025) | Net income $14b (FY, 2025) | Net income $7.8b (FY, 2025) | Net income €8b (FY, 2025) |
Operating ⚠ | |||||
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 44 (FY, 2022) | Phase III Trials Products 32 (FY, 2024) | Phase III Trials Products N/A |
Registration Phase Products | Registration Phase Products N/A | Registration Phase Products N/A | Registration Phase Products 8 (FY, 2022) | Registration Phase Products 5 (FY, 2024) | Registration Phase Products N/A |
Funding | |||||
Total funding raised | Total funding raised $ 358m | Total funding raised $ 902.6m | Total funding raised $ 6.5m | Total funding raised N/A | Total funding raised $ 310m |

WuXi AppTec (无锡药明康德新药开发股份有限公司, formerly known as WuXi PharmaTech) is a company that provides integrated research, development, and manufacturing solutions for drug discovery and production.
View company
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View company
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
View company
Sanofi is a healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions.
View company